Banner

Companion Animal Pharmaceuticals Market Report 2023 – By Animal Type (Dogs, Cats, Horses, Other Companion Animals), By Indication (Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications), By Distribution Channels (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : | Delivery Time: 2-3 business days | Format :


Companion animal pharmaceuticals refer to the pharmaceutical medication process in which animal pharmacists insist on medications, fill prescriptions, and manage drug therapies for animals. It is used in the diagnosis, mitigation, and treatment of different animal diseases.

The main types of companion animal pharmaceuticals are dogs, cats, horses, and other companion animals. Dogs refer to a highly variable carnivorous domesticated mammal of the genus closely related to the common wolf. The indications are infectious diseases, dermatologic diseases, pain, orthopaedic diseases, behavioural diseases, and other indications, which are sold through multiple distribution channels involved veterinary hospitals, veterinary clinics, and retail pharmacies.

The companion animal pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides companion animal pharmaceuticals market statistics, including companion animal pharmaceuticals industry global market size, regional shares, competitors with a companion animal pharmaceuticals market share, detailed companion animal pharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the companion animal pharmaceuticals industry. This companion animal pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.  

The global companion animal pharmaceuticals market size is expected to grow from $13.94 billion in 2022 to $15.12 billion in 2023 at a compound annual growth rate (CAGR) of 8.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The companion animal pharmaceuticals market is expected to reach $20.77 billion in 2027 at a CAGR of 8.3%.

The growing prevalence of zoonotic diseases is expected to propel the growth of the companion animal pharmaceuticals market going forward. A zoonotic illness is a disease that can be naturally transferred from vertebrate animals to humans or from people to vertebrate animals. The pharmaceutical industry is embracing modern tactics and strategies that are consistent with one set of health principles in order to combat zoonotic illnesses and lower the likelihood of transmission. For Instance, in July 2020, according to United Nations Environment Programme (UNEP), a Kenya-based authority, about 60 percent of known infectious diseases in humans and 75 % of all emerging infectious diseases are zoonotic. Therefore, the growing prevalence of zoonotic diseases is driving the growth of the companion animal pharmaceuticals market.

Embracing big data technologies is a key trend gaining popularity in the companion animal pharmaceuticals. Major companies operating in the companion animal pharmaceuticals market are focused on developing new technological solutions to strengthen their position. For Instance, in April 2022, Elanco Animal Health Incorporated, a US-based company operating in companion animal pharmaceuticals, and Ginkgo Bioworks, a US-based company operating in companion animal pharmaceuticals launched BiomEdit, a microbiome innovation company for creating innovation in animal health. This will provide novel probiotics and other related animal pharmaceuticals for animal health innovation, such as medicated feed ingredients, nutritional health and therapies for livestock and pet animals, and biosecurity technologies for animal illness monitoring.

In August 2020, Elanco Animal Health Incorporated, a US-based pharmaceutical company, acquired the business unit of Bayer Healthcare Animal Health for $6.89 billion. This acquisition would strengthen Elanco's innovation, portfolio, and productivity (IPP) strategy. Bayer Healthcare Animal Health is a Germany-based company operating in companion animal pharmaceuticals.

Major players in the companion animal pharmaceuticals  market are Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Chanelle Pharma, Eco Animal Health Group plc, Ashish Life Science Pvt. Ltd., Endovac Animal Health, Hipra Laboratories, Indian Immunologicals Ltd., Inovet Group, Kyoritsu Seiyaku Corporation, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Laboratories Ltd., Tianjin Ringpu Bio-Technology Co. Ltd., Vetoquinol S.A., Virbac S.A., Zoetis Inc., Agrolabo S.p.A., ALS Pvt. Ltd., Zydus Animal Health and Investments Limited, Eli Lily, IDEXX Laboratories Inc., Merial, and Novartis Animal Health Inc.

North America was the largest region in the companion animal pharmaceuticals market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the companion animal pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the companion animal pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and the USA.

The companion animal pharmaceuticals market includes revenues earned by entities by providing veterinary pharmaceuticals, vaccines, and health management tools.  The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global companion animal pharmaceuticals market is segmented -

1) By Animal Type: Dogs, Cats, Horses, Other Companion Animals

2) By Indication: Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications

3) By Distribution Channels: Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies

    Table Of Contents

    1. Executive Summary

    2. Companion Animal Pharmaceuticals Market Characteristics

    3. Companion Animal Pharmaceuticals Market Trends And Strategies

    4. Companion Animal Pharmaceuticals Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Companion Animal Pharmaceuticals Market

    4.2. Ukraine-Russia War Impact On Companion Animal Pharmaceuticals Market

    4.3. Impact Of High Inflation On Companion Animal Pharmaceuticals Market

    5. Companion Animal Pharmaceuticals Market Size And Growth

    5.1. Global Companion Animal Pharmaceuticals Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Companion Animal Pharmaceuticals Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Companion Animal Pharmaceuticals Market Segmentation

    6.1. Global Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Dogs

    Cats

    Horses

    Other Companion Animals

    6.2. Global Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Infectious Diseases

    Dermatologic Diseases

    Pain

    Orthopedic Diseases

    Behavioral Diseases

    Other Indications

    6.3. Global Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Veterinary Hospitals

    Veterinary Clinics

    Retail Pharmacies

    7. Companion Animal Pharmaceuticals Market Regional And Country Analysis

    7.1. Global Companion Animal Pharmaceuticals Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Companion Animal Pharmaceuticals Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Companion Animal Pharmaceuticals Market

    8.1. Asia-Pacific Companion Animal Pharmaceuticals Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Companion Animal Pharmaceuticals Market

    9.1. China Companion Animal Pharmaceuticals Market Overview

    9.2. China Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Companion Animal Pharmaceuticals Market

    10.1. India Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Companion Animal Pharmaceuticals Market

    11.1. Japan Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Companion Animal Pharmaceuticals Market

    12.1. Australia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Companion Animal Pharmaceuticals Market

    13.1. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Companion Animal Pharmaceuticals Market

    14.1. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Companion Animal Pharmaceuticals Market

    15.1. Western Europe Companion Animal Pharmaceuticals Market Overview

    15.2. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Companion Animal Pharmaceuticals Market

    16.1. UK Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Companion Animal Pharmaceuticals Market

    17.1. Germany Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Companion Animal Pharmaceuticals Market

    18.4. France Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Companion Animal Pharmaceuticals Market

    19.1. Eastern Europe Companion Animal Pharmaceuticals Market Overview

    19.2. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Companion Animal Pharmaceuticals Market

    20.1. Russia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Companion Animal Pharmaceuticals Market

    21.1. North America Companion Animal Pharmaceuticals Market Overview

    21.2. North America Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Companion Animal Pharmaceuticals Market

    22.1. USA Companion Animal Pharmaceuticals Market Overview

    22.2. USA Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Companion Animal Pharmaceuticals Market

    23.1. South America Companion Animal Pharmaceuticals Market Overview

    23.2. South America Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Companion Animal Pharmaceuticals Market

    24.1. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Companion Animal Pharmaceuticals Market

    25.1. Middle East Companion Animal Pharmaceuticals Market Overview

    25.2. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Companion Animal Pharmaceuticals Market

    26.1. Africa Companion Animal Pharmaceuticals Market Overview

    26.2. Africa Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Companion Animal Pharmaceuticals Market Competitive Landscape And Company Profiles

    27.1. Companion Animal Pharmaceuticals Market Competitive Landscape

    27.2. Companion Animal Pharmaceuticals Market Company Profiles

    27.2.1. Elanco Animal Health Incorporated

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Boehringer Ingelheim International GmbH

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Ceva Santé Animale

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Chanelle Pharma

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Eco Animal Health Group plc

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Companion Animal Pharmaceuticals Market

    29. Companion Animal Pharmaceuticals Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Companion Animal Pharmaceuticals Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Companion Animal Pharmaceuticals Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Elanco Animal Health Incorporated Financial Performance
  • Table 47: Boehringer Ingelheim International GmbH Financial Performance
  • Table 48: Ceva Santé Animale Financial Performance
  • Table 49: Chanelle Pharma Financial Performance
  • Table 50: Eco Animal Health Group plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Companion Animal Pharmaceuticals Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Companion Animal Pharmaceuticals Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Elanco Animal Health Incorporated Financial Performance
  • Figure 47: Boehringer Ingelheim International GmbH Financial Performance
  • Figure 48: Ceva Santé Animale Financial Performance
  • Figure 49: Chanelle Pharma Financial Performance
  • Figure 50: Eco Animal Health Group plc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report